title: [Clostridium difficile infection as interdisciplinary challenge. Current discussions in respect to epidemiology, diagnostic methods, risk classification as well as treatment options].
abstract: Within the last decade, the incidence ofclostridium difficile infection (CDI) has increased in many regions all over the world including the highly virulent B1/NAP1/027 strain. Meanwhile, the value of predisposing risk factors and diagnostic measures as well as the spectrum of therapeutic options has been elucidated in more detail. Most commonly applied antiinfective agents include metronidazole, vancomycin and fidaxomicin, however, several questions remain unanswered in respect to their optimized use which is also true for some further drugs which have not yet been approved for this indication. Based on the complexity and potential severity of CID, antibiotic stewardships should be implemented more intensively in order to avoid a further spread of highly virulent and resistant strains in the near future.
authors: Universitätsapotheke, Röntgenweg 9, 72076 Tübingen. Hans-Peter.Lipp@med.uni-tuebingen.de
authors: Hans-Peter
authors: HP
authors: Lipp
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D016360:Clostridioides difficile; D004761:Enterocolitis, Pseudomembranous / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology; D006801:Humans; D018570:Risk Assessment
chemical_list: D000890:Anti-Infective Agents